Octapharma Plasma, Inc. owns and operates plasma collection centers in the United States. It offers plasma products that are used to treat a range of life-threatening diseases, disorders, and conditions, including hemophilia, immune deficiencies, alpha-1 antitrypsin deficiency, and other blood-related disorders. The company was founded in 2003 and is based in Charlotte, North Carolina. Octapharma Plasma, Inc. operates as a subsidiary of Octapharma AG.